European specialist pharmaceutical company Norgine has acquired Merus Labs International for $342 million. Merus is a specialty pharmaceutical company focused on acquiring and optimizing legacy and growth products across Europe, Canada and other markets. The transaction is expected to close by September 30, 2017. Norgine offers a direct commercial presence in all major European markets. In 2016, Norgine’s total sales revenue was €295 million. It employs over 1,000 people across its comm...